Review
Published on 29 Sep 2022
Drug-related immune-mediated myelopathies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1003270
- 13,300 views
- 10 citations
Type at least 3 characters
1,194 articles
articles
Case Report
Published on 28 Sep 2022
Case report: IgG4-related intracranial lesions mimicking multiple sclerosis in a 14-year-old girl
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1007153
- 5,798 views
- 8 citations
Original Research
Published on 27 Sep 2022
Elevated monocyte to high-density lipoprotein cholesterol ratio correlates with clinical severity in acute inflammatory demyelinating polyradiculoneuropathy patients
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.955933
- 2,415 views
- 2 citations
Original Research
Published on 27 Sep 2022
Evaluation of multiple consensus criteria for autoimmune encephalitis and temporal analysis of symptoms in a pediatric encephalitis cohort
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.952317
- 5,734 views
- 6 citations
Original Research
Published on 20 Sep 2022
Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naĂŻve patients with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1012857
- 2,912 views
- 3 citations
Systematic Review
Published on 20 Sep 2022
COVID-19 and the risk of CNS demyelinating diseases: A systematic review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.970383
- 9,702 views
- 24 citations
Original Research
Published on 16 Sep 2022
Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.958441
- 3,796 views
- 7 citations
Original Research
Published on 16 Sep 2022
Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.953188
- 2,279 views
- 2 citations
Original Research
Published on 15 Sep 2022
Clinical characteristics and prognosis of anti-Îł-aminobutyric acid-B receptor encephalitis: A single-center, longitudinal study in China
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.949843
- 3,428 views
- 9 citations
Original Research
Published on 15 Sep 2022
Mendelian randomization analysis of the causal association of bone mineral density and fracture with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.993150
- 4,722 views
- 5 citations
Case Report
Published on 15 Sep 2022
IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.986694
- 5,411 views
- 6 citations
Original Research
Published on 12 Sep 2022
Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.973163
- 2,795 views
- 6 citations
Original Research
Published on 08 Sep 2022
Early predictors of visual and axonal outcomes after acute optic neuritis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.945034
- 3,334 views
- 9 citations
Original Research
Published on 06 Sep 2022
The patient journey with NMOSD: From initial diagnosis to chronic condition
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.966428
- 12,892 views
- 22 citations
Opinion
Published on 01 Sep 2022
Time to rethink the reported disease-modifying treatment effects on cognitive outcomes: Methods and interpretative caveats
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.995690
- 2,283 views
- 7 citations
Original Research
Published on 01 Sep 2022
Elevated ApoB/ApoA-I ratio is associated with acute anti-N-Methyl-D-aspartate receptor encephalitis, but not disease outcomes
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.896656
- 2,287 views
- 5 citations
Opinion
Published on 01 Sep 2022
Autoantibodies in post-treatment Lyme disease syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1004853
- 2,635 views
Editorial
Published on 30 Aug 2022
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.996342
- 2,576 views
- 2 citations
Original Research
Published on 29 Aug 2022
Somatosensory evoked potentials and their relation to microstructural damage in patients with multiple sclerosis—A whole brain DTI study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.890841
- 4,804 views
- 2 citations
Case Report
Published on 29 Aug 2022
Anti-Îł-aminobutyric acid-A receptor encephalitis with refractory seizures and cognitive impairment in a young woman: A case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.954494
- 3,506 views
- 2 citations
Original Research
Published on 29 Aug 2022
The use of functional near infrared spectroscopy and gait analysis to characterize cognitive and motor processing in early-stage patients with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.937231
- 4,365 views
- 10 citations
Case Report
Published on 29 Aug 2022
Atypical acute disseminated encephalomyelitis with systemic inflammation after a first dose of AztraZaneca COVID-19 vaccine. A case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.995875
- 6,519 views
- 6 citations
Editorial
Published on 26 Aug 2022
Editorial: Advances in neuromyelitis optica spectrum disorders
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.1005164
- 3,149 views
- 2 citations
Original Research
Published on 25 Aug 2022
Comparative analysis of clinical and imaging data of first-attack neuromyelitis optica spectrum disorders with and without connective tissue disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.969762
- 3,052 views
- 9 citations